Stocks and Investing Stocks and Investing
Wed, July 26, 2017
Tue, July 25, 2017
Mon, July 24, 2017
Fri, July 21, 2017
Thu, July 20, 2017
Wed, July 19, 2017
Tue, July 18, 2017
Mon, July 17, 2017

David Lewis Maintained (ZBH) at Buy with Increased Target to $150 on, Jul 17th, 2017


Published on 2024-10-25 21:40:00 - WOPRAI, David Lewis
  Print publication without navigation


David Lewis of Morgan Stanley, Maintained "Zimmer Biomet Holdings, Inc." (ZBH) at Buy with Increased Target from $137 to $150 on, Jul 17th, 2017.

David has made no other calls on ZBH in the last 4 months.



There are 4 other peers that have a rating on ZBH. Out of the 4 peers that are also analyzing ZBH, 2 agree with David's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Travis Steed of "Cantor Fitzgerald" Initiated at Hold and Held Target at $137 on, Friday, June 30th, 2017
  • Larry Biegelsen of "Wells Fargo" Downgraded from Buy to Hold on, Friday, April 28th, 2017


These are the ratings of the 2 analyists that currently disagree with David


  • Christopher Pasquale of "Guggenheim" Upgraded from Hold to Strong Buy on, Wednesday, July 12th, 2017
  • Isaac Ro of "Goldman Sachs" Initiated at Strong Sell and Held Target at $92 on, Tuesday, May 16th, 2017